Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Phillips

Showing results (1181-1190 of 1,197) with videos related to

Pageof 120
Sort By:
European Urology|May 22, 2025
Urine Tumor DNA to Stratify the Risk of Recurrence in Patients Treated with Atezolizumab for Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder CancerMarie-Pier St-Laurent, Parminder Singh, David J McConkey, et al.
Trials|June 18, 2021
IMI2-PainCare-BioPain-RCT3: a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by electroencephalography (EEG)André Mouraux, Petra Bloms-Funke, Irmgard Boesl, et al.
The Review of Scientific Instruments|March 3, 2016
Operation and commissioning of IFMIF (International Fusion Materials Irradiation Facility) LIPAc injectorY Okumura, R Gobin, J Knaster, et al.
Chemmedchem|March 21, 2009
Fragment-based identification of Hsp90 inhibitorsJohn J Barker, Oliver Barker, Roberto Boggio, et al.
Trials|September 5, 2022
IMI2-PainCare-BioPain-RCT2 protocol: a randomized, double-blind, placebo-controlled, crossover, multicenter trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by non-invasive neurophysiological measurements of human spinal cord and brainstem activityCaterina Leone, Giulia Di Stefano, Giuseppe Di Pietro, et al.
Trials|February 20, 2022
IMI2-PainCare-BioPain-RCT1: study protocol for a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by peripheral nerve excitability testing (NET)Zahra Nochi, Hossein Pia, Petra Bloms-Funke, et al.
Haematologica|May 24, 2015
BRCC3 mutations in myeloid neoplasmsDayong Huang, Yasunobu Nagata, Vera Grossmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2023
Development and Multicenter Case-Control Validation of Urinary Comprehensive Genomic Profiling for Urothelial Carcinoma Diagnosis, Surveillance, and Risk-PredictionKeyan Salari, Debasish Sundi, Jason J Lee, et al.
Cancer Cell|April 30, 2015
Inherited and Somatic Defects in DDX41 in Myeloid NeoplasmsChantana Polprasert, Isabell Schulze, Mikkael A Sekeres, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|October 19, 2011
The atmospheric chemistry of trace gases and particulate matter emitted by different land uses in BorneoA R MacKenzie, B Langford, T A M Pugh, et al.
Pageof 120

Showing results (1181-1190 of 1,197) with videos related to

Sort By:
Pageof 120
European Urology|May 22, 2025
Urine Tumor DNA to Stratify the Risk of Recurrence in Patients Treated with Atezolizumab for Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder CancerMarie-Pier St-Laurent, Parminder Singh, David J McConkey, et al.
Trials|June 18, 2021
IMI2-PainCare-BioPain-RCT3: a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by electroencephalography (EEG)André Mouraux, Petra Bloms-Funke, Irmgard Boesl, et al.
The Review of Scientific Instruments|March 3, 2016
Operation and commissioning of IFMIF (International Fusion Materials Irradiation Facility) LIPAc injectorY Okumura, R Gobin, J Knaster, et al.
Chemmedchem|March 21, 2009
Fragment-based identification of Hsp90 inhibitorsJohn J Barker, Oliver Barker, Roberto Boggio, et al.
Trials|September 5, 2022
IMI2-PainCare-BioPain-RCT2 protocol: a randomized, double-blind, placebo-controlled, crossover, multicenter trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by non-invasive neurophysiological measurements of human spinal cord and brainstem activityCaterina Leone, Giulia Di Stefano, Giuseppe Di Pietro, et al.
Trials|February 20, 2022
IMI2-PainCare-BioPain-RCT1: study protocol for a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by peripheral nerve excitability testing (NET)Zahra Nochi, Hossein Pia, Petra Bloms-Funke, et al.
Haematologica|May 24, 2015
BRCC3 mutations in myeloid neoplasmsDayong Huang, Yasunobu Nagata, Vera Grossmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2023
Development and Multicenter Case-Control Validation of Urinary Comprehensive Genomic Profiling for Urothelial Carcinoma Diagnosis, Surveillance, and Risk-PredictionKeyan Salari, Debasish Sundi, Jason J Lee, et al.
Cancer Cell|April 30, 2015
Inherited and Somatic Defects in DDX41 in Myeloid NeoplasmsChantana Polprasert, Isabell Schulze, Mikkael A Sekeres, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|October 19, 2011
The atmospheric chemistry of trace gases and particulate matter emitted by different land uses in BorneoA R MacKenzie, B Langford, T A M Pugh, et al.
Pageof 120